TLR4 and acute kidney injury: showed that BM-MSCs could alleviate the inflammation reaction in LPS-induced AKI in rats via downregulation of the level of TLR4 and NF-kB and inhibition of TLR4/NF-kB signaling pathway (Xiu et al., 2018).